" class="no-js "lang="en-US"> PostEra - Medtech Alert
Thursday, September 18, 2025
PostEra | Pharmtech Focus

PostEra

About PostEra

PostEra

PostEra was founded in 2019 and its technology is built on pioneering academic research done by its founding scientists. PostEra’s technology addresses some of the key challenges in drug discovery R&D by integrating molecular design with chemical synthesis. PostEra advances small molecule programs through partnerships with biopharma, working on its own internal pipeline, and also offering some of its synthesis technology via its Manifold web platform. PostEra also helped launch the world’s largest open-science drug discovery effort; COVID Moonshot, along with an NIH-funded antiviral research center for the prevention of future pandemics.

Related Story

PostEra Spearheads AI-driven Drug Discovery Collaboration to Develop Antiviral Therapeutics With Initial $68m in NIH Funding

May 19 2022

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a […]